<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2020 (5) TMI 222 - AUTHORITY FOR ADVANCE RULING, KARNATAKA</title>
    <link>https://www.taxtmi.com/caselaws?id=395189</link>
    <description>The Authority found the application admissible under Section 97(2)(b) of the CGST Act 2017. Despite the applicant&#039;s arguments, the sale of Micafungin sodium by the DTA unit was ruled not eligible for the concessional GST rate of 5%. The product, sold as a bulk drug, was deemed not to meet the criteria for classification as &quot;Micafungin Sodium for injection&quot; as per the notification, resulting in the denial of the reduced GST rate.</description>
    <language>en-us</language>
    <pubDate>Mon, 04 May 2020 00:00:00 +0530</pubDate>
    <lastBuildDate>Wed, 16 Jun 2021 12:55:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=612556" rel="self" type="application/rss+xml"/>
    <item>
      <title>2020 (5) TMI 222 - AUTHORITY FOR ADVANCE RULING, KARNATAKA</title>
      <link>https://www.taxtmi.com/caselaws?id=395189</link>
      <description>The Authority found the application admissible under Section 97(2)(b) of the CGST Act 2017. Despite the applicant&#039;s arguments, the sale of Micafungin sodium by the DTA unit was ruled not eligible for the concessional GST rate of 5%. The product, sold as a bulk drug, was deemed not to meet the criteria for classification as &quot;Micafungin Sodium for injection&quot; as per the notification, resulting in the denial of the reduced GST rate.</description>
      <category>Case-Laws</category>
      <law>GST</law>
      <pubDate>Mon, 04 May 2020 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=395189</guid>
    </item>
  </channel>
</rss>